Purchase Order 75N95018P00615
- Not listed
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $12,810 contract provides for the delivery of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Key deliverables include flow cytometers, cell sorters, tissue dissociators, automated cell...
- This is a $17,976 firm fixed price purchase order awarded to Miltenyi Biotec, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for laboratory equipment and supplies. The contract is not set aside. Miltenyi Biotec is a global biotechnology company that specializes in cell separation, analysis, and processing technologies. Under this contract, the company will provide a variety of products and services to support biomedical...
- This federal contract award to Miltenyi Biotec, Inc. is for the supply of laboratory equipment, including flow cytometers, cell sorters, tissue dissociators, and associated reagents and consumables. The $4,881 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
- This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This is a $53,081.29 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products. The contract, which does not have a set-aside designation, provides for the delivery and installation of specialized laboratory equipment such as flow cytometers, cell sorters, and cell processing systems, as well as related reagents and consumables. Many of the contract's...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an extensive history as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA. This particular award is not set aside and is part of a larger $2.3 million single-award indefinite delivery contract (IDC) the company holds with the NIH Clinical Center, providing proprietary CliniMACS cell isolation reagents and consumables through September 2024 with options to extend to 2027. The IDC ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the center's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 9/17/18 |